Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART

Jaroslaw Harezlak, R. Cohen, A. Gongvatana, M. Taylor, S. Buchthal, G. Schifitto, J. Zhong, E. S. Daar, J. R. Alger, M. Brown, E. J. Singer, T. B. Campbell, D. McMahon, Y. T. So, Constantin Yiannoutsos, B. A. Navia

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The reasons for persistent brain dysfunction in chronically HIV-infected persons on stable combined antiretroviral therapies (CART) remain unclear. Host and viral factors along with their interactions were examined in 260 HIV-infected subjects who underwent magnetic resonance spectroscopy (MRS). Metabolite concentrations (NAA/Cr, Cho/Cr, MI/Cr, and Glx/Cr) were measured in the basal ganglia, the frontal white matter, and gray matter, and the best predictive models were selected using a bootstrap-enhanced Akaike information criterion (AIC). Depending on the metabolite and brain region, age, race, HIV RNA concentration, ADC stage, duration of HIVinfection, nadir CD4, and/or their interactions were predictive of metabolite concentrations, particularly the basal ganglia NAA/Cr and the mid-frontal NAA/Cr and Glx/Cr, whereas current CD4 and the CPE index rarely or did not predict these changes. These results show for the first time that host and viral factors related to both current and past HIV status contribute to persisting cerebral metabolite abnormalities and provide a framework for further understanding neurological injury in the setting of chronic and stable disease.

Original languageEnglish
Pages (from-to)294-303
Number of pages10
JournalJournal of NeuroVirology
Volume20
Issue number3
DOIs
StatePublished - 2014

Fingerprint

HIV Infections
HIV
Wounds and Injuries
Basal Ganglia
Brain
Therapeutics
Chronic Disease
Magnetic Resonance Spectroscopy
RNA
Proton Magnetic Resonance Spectroscopy

Keywords

  • Antiretroviral therapies
  • Biomarkers
  • HIV dementia
  • HIV RNA
  • MRS
  • Neuroimaging

ASJC Scopus subject areas

  • Virology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Neurology
  • Medicine(all)

Cite this

Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. / Harezlak, Jaroslaw; Cohen, R.; Gongvatana, A.; Taylor, M.; Buchthal, S.; Schifitto, G.; Zhong, J.; Daar, E. S.; Alger, J. R.; Brown, M.; Singer, E. J.; Campbell, T. B.; McMahon, D.; So, Y. T.; Yiannoutsos, Constantin; Navia, B. A.

In: Journal of NeuroVirology, Vol. 20, No. 3, 2014, p. 294-303.

Research output: Contribution to journalArticle

Harezlak, J, Cohen, R, Gongvatana, A, Taylor, M, Buchthal, S, Schifitto, G, Zhong, J, Daar, ES, Alger, JR, Brown, M, Singer, EJ, Campbell, TB, McMahon, D, So, YT, Yiannoutsos, C & Navia, BA 2014, 'Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART', Journal of NeuroVirology, vol. 20, no. 3, pp. 294-303. https://doi.org/10.1007/s13365-014-0246-6
Harezlak, Jaroslaw ; Cohen, R. ; Gongvatana, A. ; Taylor, M. ; Buchthal, S. ; Schifitto, G. ; Zhong, J. ; Daar, E. S. ; Alger, J. R. ; Brown, M. ; Singer, E. J. ; Campbell, T. B. ; McMahon, D. ; So, Y. T. ; Yiannoutsos, Constantin ; Navia, B. A. / Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. In: Journal of NeuroVirology. 2014 ; Vol. 20, No. 3. pp. 294-303.
@article{ac7d60bb6fd449ba9106c75c8f108269,
title = "Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART",
abstract = "The reasons for persistent brain dysfunction in chronically HIV-infected persons on stable combined antiretroviral therapies (CART) remain unclear. Host and viral factors along with their interactions were examined in 260 HIV-infected subjects who underwent magnetic resonance spectroscopy (MRS). Metabolite concentrations (NAA/Cr, Cho/Cr, MI/Cr, and Glx/Cr) were measured in the basal ganglia, the frontal white matter, and gray matter, and the best predictive models were selected using a bootstrap-enhanced Akaike information criterion (AIC). Depending on the metabolite and brain region, age, race, HIV RNA concentration, ADC stage, duration of HIVinfection, nadir CD4, and/or their interactions were predictive of metabolite concentrations, particularly the basal ganglia NAA/Cr and the mid-frontal NAA/Cr and Glx/Cr, whereas current CD4 and the CPE index rarely or did not predict these changes. These results show for the first time that host and viral factors related to both current and past HIV status contribute to persisting cerebral metabolite abnormalities and provide a framework for further understanding neurological injury in the setting of chronic and stable disease.",
keywords = "Antiretroviral therapies, Biomarkers, HIV dementia, HIV RNA, MRS, Neuroimaging",
author = "Jaroslaw Harezlak and R. Cohen and A. Gongvatana and M. Taylor and S. Buchthal and G. Schifitto and J. Zhong and Daar, {E. S.} and Alger, {J. R.} and M. Brown and Singer, {E. J.} and Campbell, {T. B.} and D. McMahon and So, {Y. T.} and Constantin Yiannoutsos and Navia, {B. A.}",
year = "2014",
doi = "10.1007/s13365-014-0246-6",
language = "English",
volume = "20",
pages = "294--303",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART

AU - Harezlak, Jaroslaw

AU - Cohen, R.

AU - Gongvatana, A.

AU - Taylor, M.

AU - Buchthal, S.

AU - Schifitto, G.

AU - Zhong, J.

AU - Daar, E. S.

AU - Alger, J. R.

AU - Brown, M.

AU - Singer, E. J.

AU - Campbell, T. B.

AU - McMahon, D.

AU - So, Y. T.

AU - Yiannoutsos, Constantin

AU - Navia, B. A.

PY - 2014

Y1 - 2014

N2 - The reasons for persistent brain dysfunction in chronically HIV-infected persons on stable combined antiretroviral therapies (CART) remain unclear. Host and viral factors along with their interactions were examined in 260 HIV-infected subjects who underwent magnetic resonance spectroscopy (MRS). Metabolite concentrations (NAA/Cr, Cho/Cr, MI/Cr, and Glx/Cr) were measured in the basal ganglia, the frontal white matter, and gray matter, and the best predictive models were selected using a bootstrap-enhanced Akaike information criterion (AIC). Depending on the metabolite and brain region, age, race, HIV RNA concentration, ADC stage, duration of HIVinfection, nadir CD4, and/or their interactions were predictive of metabolite concentrations, particularly the basal ganglia NAA/Cr and the mid-frontal NAA/Cr and Glx/Cr, whereas current CD4 and the CPE index rarely or did not predict these changes. These results show for the first time that host and viral factors related to both current and past HIV status contribute to persisting cerebral metabolite abnormalities and provide a framework for further understanding neurological injury in the setting of chronic and stable disease.

AB - The reasons for persistent brain dysfunction in chronically HIV-infected persons on stable combined antiretroviral therapies (CART) remain unclear. Host and viral factors along with their interactions were examined in 260 HIV-infected subjects who underwent magnetic resonance spectroscopy (MRS). Metabolite concentrations (NAA/Cr, Cho/Cr, MI/Cr, and Glx/Cr) were measured in the basal ganglia, the frontal white matter, and gray matter, and the best predictive models were selected using a bootstrap-enhanced Akaike information criterion (AIC). Depending on the metabolite and brain region, age, race, HIV RNA concentration, ADC stage, duration of HIVinfection, nadir CD4, and/or their interactions were predictive of metabolite concentrations, particularly the basal ganglia NAA/Cr and the mid-frontal NAA/Cr and Glx/Cr, whereas current CD4 and the CPE index rarely or did not predict these changes. These results show for the first time that host and viral factors related to both current and past HIV status contribute to persisting cerebral metabolite abnormalities and provide a framework for further understanding neurological injury in the setting of chronic and stable disease.

KW - Antiretroviral therapies

KW - Biomarkers

KW - HIV dementia

KW - HIV RNA

KW - MRS

KW - Neuroimaging

UR - http://www.scopus.com/inward/record.url?scp=84905389578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905389578&partnerID=8YFLogxK

U2 - 10.1007/s13365-014-0246-6

DO - 10.1007/s13365-014-0246-6

M3 - Article

C2 - 24696364

AN - SCOPUS:84905389578

VL - 20

SP - 294

EP - 303

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 3

ER -